Hong Kong Stock Market Anomaly | Kangning Jerry Pharmaceuticals-B (09966.HK) Surges by Nearly 6% Again, Up Over 65% in the Month, JSKN003 Granted Orphan Drug Designation by US FDA
According to the Securities Times app, Kunjing Jierui Pharmaceutical-B (09966.HK) rose nearly 6% again, with a cumulative increase of over 65% in the month. As of the report, it rose by 5.86% to 10.12 Hong Kong dollars, with a turnover of 51.2966 million Hong Kong dollars.
Latest
16 m ago